Article
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy.
Circulation. Genomic and precision medicine - 1 Oct 2020
Helms Adam S, Thompson Andrea D, Glazier Amelia A, Hafeez Neha, Kabani Samat, Rodriguez Juliani, Yob Jaime M, Woolcock Helen, Mazzarotto Francesco, Lakdawala Neal K, Wittekind Samuel G, Pereira Alexandre C, Jacoby Daniel L, Colan Steven D, Ashley Euan A, Saberi Sara, Ware James S, Ingles Jodie, Semsarian Christopher, Michels Michelle, Olivotto Iacopo, Ho Carolyn Y, Day Sharlene M
Abstract excerpt
BACKGROUND: Pathogenic variants in MYBPC3, encoding cardiac MyBP-C (myosin binding protein C), are the most common cause of familial hypertrophic cardiomyopathy. A large number of unique MYBPC3 variants and relatively small genotyped hypertrophic cardiomyopathy cohorts have precluded detailed genotype-phenotype correlations. METHODS: Patients with hypertrophic cardiomyopathy and MYBPC3 variants were identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
